1e
19
1
49
2
2
18
1b
1d
18
34
63
1d
2 29
1d
25
Andrew D. Siderowf, MD
78
63
Howard Hurtig, M.D.-Matthew Stern, M.D. Professor in Neurology
7
60
Department: Neurology
4
1
b
1d
46
Contact information
43
4
3
3
3
2
4
b
1f
43
Pennsylvania Hospital
1f Department of Neurology
37 Parkinson's Disease & Movement Disorders Center
37 330 South 9th Street
Philadelphia, PA 19107
26
1f Department of Neurology
37 Parkinson's Disease & Movement Disorders Center
37 330 South 9th Street
Philadelphia, PA 19107
2e
Office: 215-829-8407
30
f
30
13
Education:
21 9 B.A. 14 (English) c
29 Yale University , 1987.
21 9 M.D. c
3b Duke University School of Medicine, 1992.
21 d M.S.C.E. c
33 University of Pennsylvania, 2003.
c
3
3
3
3
8b
Permanent link21 9 B.A. 14 (English) c
29 Yale University , 1987.
21 9 M.D. c
3b Duke University School of Medicine, 1992.
21 d M.S.C.E. c
33 University of Pennsylvania, 2003.
c
2 29
21
1e
1d
24
2b
29
27
23
124 Umemura A. Jaggi JL. Hurtig HI. Siderowf AD. Colcher A. Stern MB. : Baltuch GH. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. Journal of Neurosurgery 98(4): 779-784, Apr 2003.
c7 Siderowf A, Quinn NP. : Progressive supranuclear palsy: Setting the scene for clinical trials. Neurology 60: 892-893, 2003.
12e Siderowf AD, McDermott M, Keiburtz KD, Blindauer K, Plumb S, Shoulson I and the Parkinson Study Group. : Test-retest reliability of the UPDRS: Results from a multicenter clinical trial. Movement Disorders. 17: 758-763, 2002.
15f Simuni T, Jaggi J, Mulholland H, Hurtig H, Colcher A, Siderowf AD, Ravina B, Skolnick BE, Goldstein R, Stern MB, Baltuch GH. : Bilateral Stimulation of the Subthalamic Nucleus in Parkinson's Disease: A Study of Efficacy and Safety. Journal of Neurosurgery. 96: 666-672, 2002.
ff Gregory S, Siderowf A, Golaszewski AL, McClusky L. : Gastrostomy insertion in ALS patients with low vital capacity: Respiratory support and survival. Neurology. 58: 485-487, 2002.
d5 Siderowf AD, Ravina B. Glick HA. : Preference-based quality of life in patients with Parkinson’s disease. Neurology. 59: 103-108, 2002.
f0 Parkinson Study Group (Siderowf, A. corresponding author). : A controlled trial of rasagiline in early Parkinson disease. Archives of Neurology. 59: 1937-1943, 2002.
116 Siderowf AD, Stern MD. : Status of Neuroprotective Therapy. Parkinson’s Disease: Diagnosis and clinical management. New York. Demos Medical Publishing. Factor SA, Weiner WJ (eds.). Page: 481-494, 2002.
142 Siderowf AD, Holloway RG. : Economic burden of Parkinson’s disease: Implications for interventions. Parkinson’s Disease: Diagnosis and clinical management. New York. Demos Medical Publishing. Factor SA, Weiner WJ (eds.). Page: 639-646, 2002.
2c
7
1d
1f
Selected Publications
be Siderowf A, Stern MB. : Update on Parkinson’s Disease. Annals of Internal Medicine. 138(8): 651-658, Apr 15 2003.124 Umemura A. Jaggi JL. Hurtig HI. Siderowf AD. Colcher A. Stern MB. : Baltuch GH. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. Journal of Neurosurgery 98(4): 779-784, Apr 2003.
c7 Siderowf A, Quinn NP. : Progressive supranuclear palsy: Setting the scene for clinical trials. Neurology 60: 892-893, 2003.
12e Siderowf AD, McDermott M, Keiburtz KD, Blindauer K, Plumb S, Shoulson I and the Parkinson Study Group. : Test-retest reliability of the UPDRS: Results from a multicenter clinical trial. Movement Disorders. 17: 758-763, 2002.
15f Simuni T, Jaggi J, Mulholland H, Hurtig H, Colcher A, Siderowf AD, Ravina B, Skolnick BE, Goldstein R, Stern MB, Baltuch GH. : Bilateral Stimulation of the Subthalamic Nucleus in Parkinson's Disease: A Study of Efficacy and Safety. Journal of Neurosurgery. 96: 666-672, 2002.
ff Gregory S, Siderowf A, Golaszewski AL, McClusky L. : Gastrostomy insertion in ALS patients with low vital capacity: Respiratory support and survival. Neurology. 58: 485-487, 2002.
d5 Siderowf AD, Ravina B. Glick HA. : Preference-based quality of life in patients with Parkinson’s disease. Neurology. 59: 103-108, 2002.
f0 Parkinson Study Group (Siderowf, A. corresponding author). : A controlled trial of rasagiline in early Parkinson disease. Archives of Neurology. 59: 1937-1943, 2002.
116 Siderowf AD, Stern MD. : Status of Neuroprotective Therapy. Parkinson’s Disease: Diagnosis and clinical management. New York. Demos Medical Publishing. Factor SA, Weiner WJ (eds.). Page: 481-494, 2002.
142 Siderowf AD, Holloway RG. : Economic burden of Parkinson’s disease: Implications for interventions. Parkinson’s Disease: Diagnosis and clinical management. New York. Demos Medical Publishing. Factor SA, Weiner WJ (eds.). Page: 639-646, 2002.
2c